Latest News - GSK

Friday, March 10, 2017

Seventeen Percent of Teens Report Excessive Sweating

More teens than previously thought may experience excessive, uncontrollable sweating, according to data collected by International Hyperhidrosis Society researchers and presented at the recent Am…

Read the full story

Wednesday, December 02, 2015

Aqua Pharmaceuticals Acquires US Rights to Veltin Gel and Altabax Ointment

Aqua Pharmaceuticals, LLC acquired the US rights to two dermatology products -- Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025% and Altabax (retapamulin) Ointment 1%, after Almirall, par…

Read the full story

Thursday, November 12, 2015

GSK: Positive Phase 3 Results for Benlysta® In Patients with Systemic Lupus Erythematosus

Results from the BLISS-SC Phase 3 pivotal study in patients with active, autoantibody-positive systemic lupus erythematosus (SLE) show that Benlysta®(belimumab) 200mg administered weekly via …

Read the full story